Findings from a couple-based open trial for adult anorexia nervosa by Baucom, D.H. et al.
Findings From a Couple-Based Open Trial for Adult Anorexia Nervosa
Donald H. Baucom, Jennifer S. Kirby,
and Melanie S. Fischer




University of North Carolina at Chapel Hill
Cynthia M. Bulik
University of North Carolina at Chapel Hill
and Karolinska Institutet
Adult anorexia nervosa (AN) often is persistent, significantly erodes quality of life for both the patient
and loved ones, and carries high medical and psychiatric comorbidity. Whereas individual psychotherapy
for adult AN leads to improvement in some patients, recent findings indicate that the magnitude of
improvement is limited: Only a small percentage of individuals fully recover and dropout rates are high.
Thus, it is important to build upon current interventions to improve treatment response. We present
results from an open trial of a couple-based intervention for adult anorexia nervosa as an adjunct
treatment to standard multidisciplinary care. Twenty couples received treatment over approximately 26
weeks, including a couple-based intervention, individual CBT sessions, psychiatry visits for medication
management, and nutritional counseling sessions. The results indicate that patients improved at posttest
and 3-month follow-up on a variety of AN-related measures, anxiety and depression, and relationship
adjustment. Partners also improved on anxiety, depression, and relationship adjustment. In an exploratory
analysis, the multicomponent couple treatment intervention was benchmarked to well-conducted ran-
domized controlled trials of individual therapy for AN; the couple intervention seems to compare
favorably on AN-related measures and was associated with a lower dropout rate. In spite of method-
ological limitations, the findings suggest that including partners in the treatment of adult AN holds
potential for bolstering treatment outcomes.
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Adult anorexia nervosa (AN) is a serious, complex disorder. It
carries high medical and psychiatric comorbidity (Westmoreland,
Krantz, & Mehler, 2016) and is associated with the highest mor-
tality rate of any psychiatric disorder (Papadopoulos, Ekbom,
Brandt, & Ekselius, 2009), yet effective treatment for adult AN is
limited. That is, complete recovery rates are low (Bulik, Berkman,
Brownley, Sedway, & Lohr, 2007), and no specific form of psy-
chotherapy has been isolated as the treatment of choice (Zipfel et
al., 2014). Also, the experience of caring for someone with AN
is extremely challenging to family members (Anastasiadou,
Medina-Pradas, Sepulveda, & Treasure, 2014), and partners
report being unsure how to help [see Bulik, Baucom, & Kirby,
(2012) for a more extensive consideration of the interpersonal
aspects of AN].
These limited treatment results for adult AN are based on trials
involving various forms of individual psychotherapy accompanied
by medical management and occasionally nutritional counseling.
Three randomized controlled trials are noteworthy for employing a
multimodal treatment (McIntosh et al., 2005; Schmidt et al., 2015
[MOSAIC]; Zipfel et al., 2014 [ANTOP]), and the findings from
these investigations were similar and reflect results from smaller
investigations as well (Bulik et al., 2007). In these trials, no
convincing and sustained differences emerged between “control”
conditions and specialized therapies with regard to recovery at
posttest, with recovery rates varying only between 5% and 12%.
Furthermore, average gains in BMI (1.0, 0.78, 0.93 kg/m2 for the
McIntosh et al., ANTOP, and MOSAIC studies, respectively) were
modest in all trials with no significant differences among condi-
tions in any study at posttest or follow-up (Carter et al., 2011;
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Schmidt et al., 2016). A further challenge is that dropout from
treatment is high—approximately 25% in psychotherapy trials
(Berkman et al., 2006). Thus, the development of interventions
that are more effective for adult AN and are acceptable to patients
is essential.
Treatment findings from two related domains suggest that one
potential strategy for improving treatment for adult AN is to
include partners in the intervention. First, Family Based Treatment
(FBT), which incorporates parents into treatment for youth with
AN, is a promising evidence-based intervention for this age group
(Bailey et al., 2014; Bulik et al., 2007), and pilot investigations
have explored the feasibility and acceptability of incorporating
support adults (i.e., parents, siblings, partners, other relatives, or
friends) into treatment for the disorder, adapting either FBT or
other forms of family therapy, or including support persons in a
CBT framework. For example, the MOSAIC study (Schmidt et al.,
2015) offered two sessions with a close other. Findings demon-
strate reasonable acceptability of these interventions (Chen et al.,
2016; Dimitropoulos, Farquhar, Freeman, Colton, & Olmsted,
2015; Doba, Pezard, Berna, Vignau, & Nandrino, 2013; Reyes-
Rodriguez, Bulik, Hamer, & Baucom, 2013; Schmidt et al., 2015).
Therefore, developing appropriate ways to incorporate family
members such as partners into treatment for adult AN might
facilitate treatment efficacy.
In addition, a second treatment tradition that supports the inclu-
sion of partners in the treatment of adult AN derives from
cognitive–behavioral couple therapy (CBCT; Epstein & Baucom,
2002). CBCT has been demonstrated to assist a wide range of
couples, including both distressed and nondistressed, make adap-
tive changes in overall relationship adjustment and specific do-
mains such as communication. Couple-based interventions from a
CBCT perspective also have demonstrated efficacy in assisting
couples with other psychological disorders, including those highly
comorbid with AN, such as anxiety and depression (Fischer,
Baucom, & Cohen, 2016). Thus, couple-based interventions for
other adult disorders are effective while also improving relation-
ships, supporting the development of couple-based interventions
for AN.
Based on the utility of adapting CBCT to treat other psycho-
logical disorders and the record of FBT for treating younger
individuals with AN, a cognitive–behavioral approach was devel-
oped for the current couple-based intervention [Uniting Couples in
the treatment of Anorexia Nervosa (UCAN)]. Consistent with
current treatment guidelines for AN (Workgroup on Eating Dis-
orders, 2006), UCAN was developed as a component of a multi-
component treatment including individual CBT, medical manage-
ment, and nutritional counseling. UCAN builds on existing
treatments by incorporating principles from individual CBT for
AN placed in an interpersonal context.
We initially began the investigation by comparing UCAN to
unscripted couple therapy. However, given the challenge of treat-
ing couples in which one partner has AN, we ultimately adopted an
open trial approach, offering UCAN to all couples enrolling later
in the trial. Based on findings described above, we hypothesized
that patients with AN in our multicomponent couple treatment
(MCCT) would demonstrate significant improvements in three
domains: (a) BMI and AN symptoms; (b) depression and anxiety;
and (c) relationship adjustment. Given the stress that AN places on
partners, we expected that partners would report improvements in
(a) depression and anxiety and (b) relationship adjustment. Also, it
was expected that the changes would maintain over short-term
follow-up. Finally, given the presence of the partner to assist when
the patient’s motivation lags, we anticipated lower dropout rate
from MCCT in comparison to previous trials of individual psy-
chotherapy. Because there was no comparison condition in the
current trial and no previous couple-based randomized controlled
trial (RCTs) for adult AN, we employed exploratory benchmarking
strategies to compare BMI changes in MCCT to the McIntosh et al.
(2005) and ANTOP (2014) investigations. Because these previous
RCTs involved approaching AN as a multidisciplinary team in-
cluding individual therapy, medical management, and nutritional
counseling, the couple component is the only new modality of
intervention not included in these two trials. The MOSAIC trial is
not included in these analyses as it did include some sessions with
a close other. At the same time, these comparisons are presented
only as exploratory since these earlier trials differ from the current
intervention in numerous ways.
Method
Participants
Twenty couples in which one partner suffered from AN were
recruited through contact with mental health professionals and
facilities providing treatment for AN, flyers, electronic ads, and
email listserv announcements. Adults of both sexes and any sexual
orientation were eligible, but only couples with the female partner
suffering from AN and their male partners entered the study.
Participants had to be at least 18 years old, in a committed
relationship, and cohabiting for at least one year with a partner
willing to participate. Patients had to meet DSM–IV criteria for AN
at the time of assessment (except for criterion D—amenorrhea),
with a BMI between 16 and 19 kg/m2 at the beginning of the study.
Exclusion criteria were alcohol or drug dependence in the past
year, current significant suicidal ideation reported at the assess-
ment, developmental disability that would impair ability to benefit
from the treatment, and psychosis (i.e., schizophrenia, bipolar I
disorder).
On average, patients were 33.20 (SD  9.15) and partners were
35.60 (SD  9.37) years old. Among patients, 85% identified as
White, 10% Black, 5% Asian American. Among partners, 95%
identified as White and 5% Black. No patients or partners identi-
fied as Hispanic. Seventy percent of patients and 45% of partners
had a college degree or higher; median household income was
$25,000–$34,999 and ranged from under $5,000 to $100,000–
$249,999. Couples had been romantically involved for an average
of 10.78 years (SD  9.67). Eleven couples had children (number
of children: M  2.27, SD  1.35). In addition to AN, patients on
average had 2.0 (SD  2.0, ranging from 0 to 8) comorbid
psychiatric diagnoses, based on the Structured Clinical Interview
for DSM (SCID) administered at pretest. Seventy percent of pa-
tients and 15% of partners had at least one comorbid anxiety
disorder (including obsessive–compulsive disorder); 45% of pa-
tients and 5% of partners had a comorbid mood disorder.
Materials
Measures in three categories were given at pretest, posttest, and
3-month follow-up: (a) AN-specific measures, (b) measures of
depression and anxiety, and (c) measures of relationship adjust-
ment. Additional measures not focal to the outcome portion of the
investigation were completed, but they are not reported here.
Couples were paid $50 to complete the measures at posttest and
follow-up and received treatment free of charge.
AN-specific measures. The following weight and eating re-
lated measures were completed by patients only.
Body mass index (BMI). Weight was measured using a reg-
ularly calibrated digital scale; enrollment weight was used in
calculating pretest weight in the analyses. A fixed stadiometer was
used to assess height at pretest. BMI was calculated as weight (in
kilograms)/height2 (in meters). Given the nature of AN, we al-
lowed for two stabilizing hospitalizations during the course of the
clinical trial at any point after enrollment. We also recorded BMI
just prior to the first session for all patients, and it is reported as
well.
Eating Disorders Examination (EDE; Fairburn, Cooper, &
O’Connor, 2008). The EDE is a standardized interview to assess
eating disorder symptoms, resulting in scale scores in four areas:
(a) dietary restraint, (b) concerns and behaviors related to eating,
(c) concerns and behaviors related to body shape, and (d) concerns
and behaviors related to weight. A global score ranging from 0 to
6 is derived by averaging the scale scores; higher scores reflect
more symptoms. The EDE is a valid and reliable assessment of
eating disorder symptoms (Berg, Peterson, Frazier, & Crow,
2012). In the current study, the alpha for patients was .93.
Global recovery index. A global recovery index with three
categories (recovered, intermediate, poor) was created for the
current investigation, similar to the indexes employed by McIntosh
et al. (2005) and Zipfel et al. (2014). The index accounted for
physical recovery (BMI), behavioral recovery (number of objec-
tive bulimic episodes, self-induced vomiting, and number of days
with 8 or more waking hours without eating; all assessed with the
EDE), and psychological recovery (scores on the four EDE sub-
scales). Behavioral recovery was considered achieved in patients
who were abstinent from all behaviors (binge eating, vomiting,
restrictive eating) in the past 28 days. Psychological recovery was
considered to be met when patient scores fell within one SD of the
population norms on all EDE subscales (Fairburn et al., 2008). In
order to be categorized as recovered, patients had to meet the
following criteria: (a) BMI 18.5 kg/m2 plus the behavioral and/or
physical recovery criterion met, or (b) BMI between 17.5 and 18.5
kg/m2 plus both the behavioral and physical recovery criteria met.
A BMI 17.5 kg/m2 was considered a poor outcome regardless of
the psychological and behavioral components; likewise, a BMI
between 17.5 and 18.5 kg/m2 in the absence of the behavioral and
psychological recovery criteria being met was also considered
poor outcome. All other outcomes were considered intermediate.
Non-AN measures of psychopathology. Both the patient and
the partner completed measures of depression and anxiety to assess
individual distress not focal to AN. The Beck Depression
Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) is a 21-item
self-report questionnaire that is frequently used to assess the se-
verity of depressive symptoms in the past two weeks; the BDI has
good internal consistency, test–retest reliability, and validity (Do-
zois, Dobson, & Ahnberg, 1998). In the current sample, the BDI
had high internal consistency with a Cronbach’s alpha  .89 for
patients and   .87 for partners. The Beck Anxiety Inventory
(BAI; Beck & Steer, 1993) is a 21-item, frequently used self-report
measure of anxiety. Convergence with other measures of anxiety
has been demonstrated; reliability and validity are good (Bardho-
shi, Duncan, & Erford, 2016). In the current study, alphas were .91
and .86 for patients and partners, respectively.
Relationship adjustment. Global relationship adjustment
was assessed in both partners using the Dyadic Adjustment Scale-4
(DAS-4; Sabourin, Valois, & Lussier, 2005), a four-item revision
of the original Dyadic Adjustment Scale (DAS, Spanier, 1976).
The DAS is one of the most widely used measures of relationship
adjustment. Sabourin et al. demonstrated that the DAS-4 is as
informative at all levels of couple satisfaction and is as effective at
predicting couple dissolution when compared to the original 32-
item DAS. The alphas in the current sample were .92 for patients
and .86 for partners; a score below 13 indicates relationship
distress.
Procedure
All study procedures were approved by the UNC institutional
review board.
Study design. The current study was conducted with an
NIMH award supporting the development and testing of innova-
tive treatments for adult AN, given the limited effectiveness of
existing treatments. Within this context, the study was originally
planned as an RCT comparing the MCCT intervention (UCAN
couple therapy, individual CBT, medical management, nutritional
counseling) to a supportive couple therapy treatment package
(supportive couple therapy, individual CBT, medical management,
nutritional counseling). However, during the trial it became clear
that it would not be possible to develop UCAN and attain an
adequately powered sample size within the 3-year study duration.
We therefore opted to discontinue randomization and converted
the investigation into an open trial enrolling all remaining couples
into the UCAN intervention, in order to provide adequate prelim-
inary efficacy data for this novel intervention. This approach
resulted in 13 couples receiving the UCAN intervention and 7
couples receiving the supportive couple therapy treatment pack-
age; both groups of couples are considered together as MCCT in
the analyses, as explained below.
Treatment. All patients received treatment over approxi-
mately 26 weeks, including: 22 weekly sessions of a couple-based
intervention, along with 22 individual CBT sessions, biweekly
psychiatry visits for medication management, and nutritional coun-
seling (beginning with weekly sessions and tapered later).
UCAN couple therapy. The UCAN couple intervention uses
a CBCT approach and includes several intervention components
outlined in a session-by-session treatment manual. A detailed
description of all treatment interventions can be found elsewhere
(Bulik et al., 2012; Bulik, Baucom, Kirby, & Pisetsky, 2011); what
follows is an overview. The first phase of UCAN presents psy-
choeducation about AN and the recovery process, followed by
training in communication skills to help the couple share thoughts
and feelings and make effective decisions, within the context of
couples’ conversations about AN. Second, the major portion of
UCAN focuses on helping the couple address eating-disordered
behavior, including (a) how to arrange their environment for
healthful eating, exercise, and other relevant behavioral patterns,
and (b) addressing concerns around eating in public and changing
unhelpful couple interaction patterns (e.g., partner trying to control
patient’s eating behaviors) toward more appropriate strategies
(e.g., problem-solving around how the couple will respond if the
partner notices eating-disordered behaviors). In the third phase,
couples consider how to address body image, affection, and sexual
concerns. Finally, relapse prevention is discussed in regard both to
AN-related behaviors as well as couple interaction patterns.
Supportive couple therapy. The supportive couple inter-
vention allowed the couple therapist to address AN issues in
any way the therapist thought would be beneficial to the spe-
cific couple. The couples were not taught specific communica-
tion skills, and the therapist was not asked to follow a particular
protocol. No treatment manual was provided.
Results
Data Analytic Approach
Because only seven couples were seen in the supportive couple
therapy component, a comparison between the two conditions was
not possible on the various analyses described below involving
inferential statistics due to very limited power to detect group
differences. On the broadest primary outcome measure at posttest,
the Global Recovery Index, the two groups were essentially iden-
tical in the proportion of patients improving/recovering. On a more
general descriptive level, the results indicated no striking differ-
ences in outcome between the two conditions on the outcome
measures described below, so the data were aggregated across
conditions and treated as an open trial of MCCT. A series of
analyses was used to test the statistical significance, within-group
effect sizes, and clinical significance of changes over time. In
order to provide some basis for comparing the results to more
established findings from RCTs for adult AN including individual
treatment, the magnitude of within-group effect sizes for BMI was
compared in an exploratory fashion to those reported by McIntosh
et al. (2005) and Zipfel et al. (2014) using benchmarking proce-
dures. These latter trials included similar treatment components,
except for the couple therapy that is unique to the current trial; yet
other methodological differences among the studies merit caution
in reaching conclusions regarding the relative impact of treatment
across investigations.
All outcome variables had some amount of missing data, and
analyses were therefore performed using recommended intent to
treat methods (e.g., White, Horton, Carpenter, & Pocock, 2011).
More specifically, all analyses reported below were conducted
using five imputed data sets generated using methods recom-
mended for multiply nested designs (i.e., fully conditional speci-
fication; Van Buren, 2011). In order to examine the stability of
findings regarding statistically significant change, additional sen-
sitivity analyses of statistically significant change were performed
for all outcomes using multilevel modeling (MLMs) estimated
using the original, unimputed data as well as using cases with
complete data at pretest and posttest or pretest and follow-up
(available from the first author). All findings regarding statistically
significant change were stable across these approaches, with the
one exception that pre- to posttest change in the EDE was some-
what more unstable (marginally significant for imputed data, sig-
nificant in the MLM and completer analyses).
Within-group effect sizes were estimated by averaging the
means and standard deviations of the imputed data sets and com-
puted using the standard deviation of the relevant variable at
pretest. Comparisons of effect sizes for BMI in the current study to
those reported in McIntosh et al. (2005) and Zipfel et al. (2014)
were conducted using procedures outlined in Minami, Serlin,
Wampold, Kircher, and Brown (2008). Clinically significant
change categories were calculated using formulas provided in
Jacobson and Truax (1991). We additionally report the number of
participants in the unchanged or deteriorated categories whose
scores are in the healthy range on each outcome.
Primary Outcomes
Of the 20 couples enrolled in the study, 18 completed treatment.
The dropout rate in the current investigation was 10%. [Previous
investigations of treatments for adult AN have reported dropout rates
averaging 25% (Berkman et al., 2006), ranging from 9% to 41%].
BMI. As shown in Table 1, BMI improved significantly from
pretest to posttest and from pretest to follow-up. Mean BMI increased
from 16.74 kg/m2 at pretest to 19.83 kg/m2 at posttest and 20.17
kg/m2 at follow-up, with corresponding within-group effect sizes of
ES  1.92 and ES  2.13. Consistent with the within-group changes
Table 1
Mean Scores (Standard Deviations) on Treatment Outcome Variables at All Assessment Points, Test Statistics (T-Tests for BMI and
EDE, Fixed Main Effects for Measures Completed by Both Partners), and Within-Group Effect Sizes (Changes From Pre)
Variable
Pre Posttest Follow-up
Mean (SD) Mean (SD) Test statistica ES Mean (SD) Test statistica ES
BMI – patient 16.74 (1.61) 19.83 (2.48) t(19)  7.64 1.92 20.17 (2.26) t(19)  2.67 2.13
EDE – patient 3.11 (1.49) 2.56 (1.56) t(19)  1.71; p  .087 .37 2.23 (1.19) t(19)  2.90 .59
BAI – patient 20.49 (12.10) 14.91 (12.04) B  3.81 (1.81) .46 12.49 (9.46) B  4.60 (1.68) .66
BAI – partner 3.58 (4.74) 1.55 (2.54) .43 2.38 (2.75) .25
BDI – patient 27.84 (12.28) 16.35 (15.48) B  7.94 (3.13) .94 12.36 (12.84) B  10.80 (4.97) 1.26
BDI – partner 7.90 (7.01) 4.12 (5.58) .54 4.39 (5.33) .50
DAS-4 – patient 13.15 (4.83) 15.11 (3.98) B  1.54 (.72) .41 15.50 (72) B  2.20 (1.02) .49
DAS-4 – partner 12.15 (3.87) 13.28 (3.98) .29 14.21 (3.96) .53
Note. ES  (within-group) effect size; BMI  Body mass index; EDE  Eating Disorders Examination; BAI  Beck Anxiety Inventory; BDI  Beck
Depression Inventory; DAS-4  Dyadic Adjustment Scale-4.
a Test statistics are based on repeated measures t-test for BMI and EDE and based on MLM for all other outcomes where data was nested within couples.
 p  .05.  p  .01.  p  .001.
described above, the analyses of clinically significant change also
indicated meaningful increases in BMI for the majority of patients
(see Table 2); 65% of patients at posttest and 75% at follow-up had
crossed into the healthy range for BMI (18.5 kg/m2).
When using the BMI measured prior to the first session of MCCT,
following hospital stays for some patients after enrolling in the study,
changes in BMI at posttest and follow-up were still significant,
although effect sizes were smaller. Clinically significant change anal-
yses using this BMI showed that 55% of patients at posttest and 70%
at follow-up had improved and crossed into the healthy range for
BMI. At posttest, 25% had deteriorated and 5% were unchanged; at
follow-up, only 5% had deteriorated and none were unchanged.
EDE. In addition to increases in BMI, significant improve-
ments were also observed in the EDE global score. The reduction
in EDE scores were statistically significant for all time points, and
the within-group effect sizes were .37 and .59, respectively
(see Table 1). The clinically significant change analyses for the
EDE also suggest that changes were clinically meaningful for a
large proportion of patients (see Table 2).
Global recovery index. The overall pattern of significant and
clinically meaningful improvements in terms of weight status and AN
symptoms was further supported by changes in the global recovery
index. More specifically, the number of patients with poor status
greatly decreased from 80% at pretest to 30% and 20% at posttest and
follow-up, respectively. At the end of treatment, 25% of patients were
categorized as having recovered, and this number increased to 30% at
follow-up. These rates were even more favorable when analyzing
completers with available data only (instead of using the dataset with
imputed scores): 38% of completers were categorized as recovered at
posttest, and this number increased to 50% at follow-up.
Thus, all analyses focusing on AN symptoms (BMI and EDE)
consistently showed significant and clinically meaningful im-
provements for a majority of patients.
Secondary Outcomes: Patient and Partner Depression
and Anxiety
In addition to the improvements in AN symptoms, patients and
partners also improved in broader domains of individual function-
ing. More specifically, BDI and BAI symptoms improved signif-
icantly from pretest to posttest and from pretest to follow-up for
both patients and partners, with effect sizes ranging from .25 to
1.26 (see Table 1). Across partners, changes on the BDI and BAI
correlated .48, indicating some overlap but suggesting they are
separate phenomena. Patients reported notably greater anxiety and
depressive symptoms at pretest than partners (see Table 1), but
there were no significant spousetime interactions, indicating pa-
tients and partners changed at rates that were not significantly
different from one another. For the BDI, the clinically significant
change analyses indicated that the majority of patients improved
significantly, 60% at posttest and 75% at follow-up. Among part-
ners, 35% at posttest and 45% at follow-up had improved signif-
icantly on the BDI (see Table 2 for details). For the BAI, the
clinically significant change analyses indicated that 30% of pa-
tients had improved significantly at posttest and 45% at follow-up.
Among partners, 25% had significantly improved at posttest and
follow-up (see Table 2).
In summary, following the MCCT, depression and anxiety de-
creased for both patients and partners. Partners’ levels of depres-
sion and anxiety were relatively low at pretest, but nevertheless
improved following MCCT.
Secondary Outcomes: Interpersonal Functioning
Relationship adjustment improved significantly and equally for
patients and partners across all time points, with effect sizes
ranging from .29 to .53 (see Table 1). Clinically significant change
analyses indicated that at posttest, 45% of patients and 40% of
partners improved significantly on the DAS-4; at follow-up, 45%
of patients and 50% of partners had improved significantly (see
Table 2). Thus, even though the treatment did not focus on rela-
tionship distress, relationship adjustment improved significantly
and at a clinically meaningful level for both patients and partners.
Exploratory Benchmarking Comparisons
In the absence of a comparison group, we compared BMI
outcomes to those reported in other published clinical trials for the
Table 2
Percent of Individuals in Clinically Significant Change Categories at Posttest and Follow-Up
Variable
Pretest/Posttest Pretest/Follow-up
Det. (healthy)a Unch. (healthy)a Improv. Recov. Det. (healthy)a Unch. (healthy)a Improv. Recov.
BMI 0% 0% 35% 65% 0% 0% 25% 75%
EDE 15% (0%) 40% (5%) 25% 20% 10% (0%) 15% (5%) 55% 20%
BAI
Patient 0% (0%) 70% (50%) 5% 25% 0% (0%) 55% (40%) 10% 35%
Partner 0% (0%) 75% (40%) 15% 10% 10% (5%) 65% (40%) 10% 15%
BDI
Patient 20% (0%) 20% (10%) 20% 40% 5% (0%) 20% (5%) 20% 55%
Partner 5% (0%) 60% (35%) 20% 15% 10% (5%) 45% (25%) 15% 30%
DAS-4
Patient 15% (10%) 40% (25%) 10% 35% 10% (10%) 45% (40%) 5% 40%
Partner 10% (5%) 50% (30%) 5% 35% 10% (10%) 40% (35%) 5% 45%
Note. BMI  Body mass index; EDE  Eating Disorders Examination; BAI  Beck Anxiety Inventory; BDI  Beck Depression Inventory; DAS-4 
Dyadic Adjustment Scale-4; Det  Deteriorated; Unch  Unchanged; Improv.  Improved; Recov.  Recovered.
a denotes % of all individuals who deteriorated or did not change but were in the healthy range at post or follow-up.
treatment of adult AN that did not include a close other, recog-
nizing that differences among these various investigations require
caution in reaching conclusions regarding relative effectiveness of
treatment. Across both test statistics, the within-group effect sizes
in the current study for change from pretest to post treatment were
significantly larger than every treatment condition in Zipfel et al.
(2014) and McIntosh et al. (2005), 2.18  t  3.09, with one
exception: Compared to specialized supportive clinical manage-
ment (SSCM) in McIntosh et al. (2005), the t test, t(34)  1.33,
p  .19 was not significant, which suggests that the effect size in
MCCT was not significantly different than that for SSCM. How-
ever, the critical noncentral d index (d  1.52) suggests that the
effect size for BMI in MCCT (d  1.92) was larger than that seen
in SSCM. The effect sizes across the three conditions in Zipfel et
al.’s study (2014) ranged from .62 to 1.00 and across the three
conditions in McIntosh’s study (2005) from .34 to .90. Thus, the
effect size for MCCT in the current study for BMI at posttest
(ES  1.92) was approximately 1.9 times to 5.6 times larger than
the effect sizes for the individual treatments in the two benchmark
studies. Likewise, comparing recovery rates, at the end of treat-
ment, 25% of current patients were categorized as having recov-
ered [compared to 5%–10% in McIntosh et al. (2005) and Zipfel et
al. (2014)], and this number increased to 30% at follow-up. Com-
plete details of these analyses are available from the first author.
Discussion
The findings from the current investigation are promising and
suggest that adding a couple treatment to a typical multidisci-
plinary intervention package has the potential to boost treatment
response in adult AN. First, the most central outcomes of concern
involved weight gain (BMI) and improvement in AN symptoms.
These domains were explored in a variety of ways, and in almost
every instance, the gains from pretreatment to posttreatment were
noteworthy. Likewise, when a more comprehensive measure of
recovery was explored (global recovery index), the recovery rate
was 25%, which still leaves substantial room for improvement, yet
is higher than seen in previous RCTs employing individual therapy
(Bulik et al., 2007). Thus, adding couple treatment to existing
multicomponent interventions might notably improve adult AN
treatment outcome.
In addition, the findings suggest that the treatment benefited
both patients and partners in important individual and relationship
domains beyond AN symptoms. Both patients and partners showed
significant decreases in both depression and anxiety, and both
patients and partners increased in relationship adjustment at post-
test and follow-up. These improvements in relationship adjustment
along with improving targeted symptoms of the disorder are con-
sistent with previous couple-based intervention trials for other
disorders, such as meta-analytic findings for depression (Barbato
& D’Avanzo, 2008) and our open couple-based trial for OCD
(Abramowitz et al., 2013). This cumulative set of findings from the
current investigation seem to be adding to a developing picture that
working with a couple around a given person’s psychological
disorder might have the benefit of addressing the specific disorder,
along with improving broader indices of distress for both persons,
and helping to improve relationship adjustment. To the degree that
this emerging patterns is valid, the mechanisms of change that lead
to greater individual and relationship adjustment are unclear but
warrant further investigation.
A final important area of treatment response involves patients
discontinuing treatment prematurely, which historically has been a
substantial impediment to providing effective treatment for adult
AN. As noted earlier, across psychotherapy trials for adult AN,
dropout rates average approximately 25% (Berkman et al., 2006),
and in the current investigation, only 10% of couples dropped out
of treatment. Our clinical observations of factors that might have
contributed to this low dropout were that many couples had a
shared sense of commitment to coming to treatment that facilitated
adherence, even when individual motivation was low, although we
have no empirical measures to support this observation. In addi-
tion, the individuals in the current investigation are unique in that
both the patient and partner agreed to have the partner as a central
part of treatment. Thus, there could be unique characteristics of
these couples that contributed to low dropout relative to other
treatment trials. At the same time, these couples were not merely
a group of happy, well-functioning couples. They demonstrated a
wide range of relationship adjustment at pretest, as a group scoring
very near the cutoff between distressed and nondistressed, and
clinicians often remarked how challenging the couple intervention
was.
However, these findings must be interpreted with caution given
the small sample size and open trial design, which changed during
the course of the investigation. Because this was an initial trial
without a comparison condition, it is helpful to put the findings in
some context by comparing the treatment gains to previous inves-
tigations. Therefore, we conducted exploratory benchmarking
strategies to compare the current results to the two largest RCTs
for adult AN (that did not include a partner or selected other)
(McIntosh et al., 2005; Zipfel et al., 2014). A benefit of this
comparison is that these previous RCTs and the current trial all
included some form of individual therapy, medical management,
and nutritional counseling. Thus, the current trial added only the
couple intervention. At the same time, the comparisons are only
broad estimates and rough comparisons because as is almost
always the case, the treatment trials vary in multiple ways, includ-
ing setting (both RCTs were conducted in countries other than the
U.S.), therapists, length of treatment, and patient characteristics
[for example, in the current investigation, patients exhibited more
extensive comorbid psychopathology than in the ANTOP study
(mood disorders: 45% vs. 24% and anxiety disorders: 70% vs.
24%, respectively)]. Given these limitations, the findings suggest
that the couple-based intervention compares favorably relative to
the previous RCTs in addressing AN symptoms. In terms of BMI,
the current effect size was approximately 1.9 times to 5.6 times
larger than the effect sizes for the individual treatments in the two
benchmark studies; on the broader recovery index, more than twice
as many patients recovered compared to the benchmarked trials.
These findings are promising, although the findings clearly call for
an RCT so that direct comparisons can be made across treatment
conditions.
Whereas the present findings suggest the possible utility of
incorporating a partner into treatment of adult AN, it must be
acknowledged that this multicomponent intervention is complex
and requires professional expertise. Whereas the other components
of the intervention (i.e., individual therapy, medical management,
and nutritional counseling) are routine in many specialist settings
that treat AN, the couple intervention component is unique. This
requires a provider with expertise to provide the couple treatment,
as well as the presence of a willing partner to participate. Whereas
individuals with AN enter into committed relationships at rates
comparable to healthy peers (Maxwell et al., 2011), many individ-
uals do not have a partner or the partner might be unwilling or
unable to participate, so the current treatment will not serve all AN
patients. In addition, the most effective way to incorporate a
partner into treatment is unknown at present. It is yet to be
determined whether some benefit might result from incorporating
partners into treatment in a more limited manner (i.e., receiving
psychoeducation about AN and explaining the patient’s treatment
goals).
In summary, the results of the current investigation are prom-
ising while posing many new questions requiring empirical inves-
tigation. Skilled researchers and clinicians have devoted consider-
able effort over decades to develop efficacious interventions for
AN, one of the most complex psychiatric disorders to treat. The
results of recent RCTs indicate that a variety of individual treat-
ment approaches do promote change, yet improvements from
individual therapy are less than optimal. Thus, expanding our
treatment paradigm is needed, and building from current treatment
approaches to incorporate working with the couple as a team
appears to be one fruitful avenue that merits further consideration.
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